Therapeutic Effect of 48 h after Nigella sativa Extract Administration on Female Wistar Rats Vaginal Candidiasis Model: An Experimental Study

Authors

  • Muhammad Rusda Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  • Ichwanul Adenin Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  • M. Fidel Ganis Siregar Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  • Andrina Y. M. Rambe Department of Otorhinolaryngology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  • Yudha Sudewo Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2021.5904

Keywords:

Fungal Inoculation, Pseudoestrus, Candida albicans, Nigella sativa, Vulvovaginal Candidiasis, Fluconazole

Abstract

BACKGROUND: Candida albicans was the common causes of vulvovaginalis candidiasis (VVC) in human. To avoid complications, prompt and proper treatment of VVC must be performed. The pharmacological effects of Nigella sativa include antimicrobial, anti-inflammatory, immune stimulation, and anti-cancer properties.

AIM: N. sativa has been shown to have an in vivo antifungal effect and the purpose of this study was to determine the antifungal and potential in vivo therapeutic effects.

METHODS: This research was an empirical study which evaluated the therapeutic effect of the vaginal candidiasis model of N. sativa in rats. The subjects were 28 rats inoculated with C. albicans and were divided into four groups: Control group (G1), fluconazole group (G2), N. sativa group (G3), and N. sativa and fluconazole group combinations (G4). The colony of C. albicans was assessed to determine the treatment’s therapeutic effect.

RESULTS: There was no difference in the number of colonies of C. albicans between all the pre-inoculation (p = 0.274) and post-inoculation (p = 0.323) classes. A substantial decrease in the number of C. albicans colonies within 48 h of treatment was observed between the three control group treatment forms (N. sativa group p = 0.046; fluconazole group p = 0.002; and N. sativa + fluconazole group p = 0.002).

CONCLUSIONS: The therapeutic effect of N. sativa has been achieved by reducing the number of colonies of C. albicans.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Bita A, Rosu A, Calina D, Rosu L. An alternative treatment for Candida infections with Nigella sativa extracts. Eur J Hosp Pharm. 2012;19(2):162. https://doi.org/10.1136/ejhpharm-2012-000074.203

Al-Ahmadey ZZ, Mohamed SA. Vulvovaginal candidiasis: Agents and its virulence factors. Microbiol Res Int. 2014;2(3):28-37.

Sahoo S, Mohanty I, Parida B, Patnaik S. Prevalence of vulvovaginal candidiasis in sexually active females with antifungal susceptibility patterns of the isolates. Int J Clin Biomed Res. 2018;4(2):38-41. https://doi.org/10.5455/ijcbr.2018.42.09

Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi KA, Siddique NA, et al. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed. 2013;3(5):337- 52. https://doi.org/10.1016/s2221-1691(13)60075-1 PMid:23646296

Al-Beitawi NA, El-Ghousein SS, Nofal AH. Replacing bacitracin methylene disalicylate by crushed Nigella sativa seeds in broiler rations and its effects on growth, blood constituents and immunity. Livest Sci. 2009;125(2-3):304-7. https://doi.org/10.1016/j.livsci.2009.03.012

Aljabre SH. Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone. J Ethnopharmacol. 2005;101(1-3):116-9. https://doi.org/10.1016/j.jep.2005.04.002 PMid:15908151

Candel FJ, Pazos Pacheco C, Ruiz-Camps I, Maseda E, Sánchez-Benito MR, Montero A, et al. Update on management of invasive candidiasis. Rev Esp Quimioter. 2017;30(6):397-406. PMid:29115366

Chaieb K, Kouidhi B, Jrah H, Mahdouani K, Bakhrouf A. Antibacterial activity of thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complement Altern Med. 2011;29(11):29. https://doi.org/10.1186/1472-6882-11-29

De Bernardis F, Santoni G, Boccanera M, Spreghini E, Adriani D, Morelli L, et al. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect Immun. 2000;68(6):3297-304. https://doi.org/10.1128/iai.68.6.3297-3304.2000 PMid:10816477

Fidel PL, Cutright J, Steele C. Effects of reproductive hormones on experimental vaginal candidiasis. Infect Immun. 2000;68(2):651-7. https://doi.org/10.1128/iai.68.2.651-657.2000 PMid:10639429

Joly V, Yeni P. Rodent models of Candida sepsis. In: Zak O, Sande M, editors. Handbook of Animal Models of Infection. Cambridge, MA: Academic Press; 1999. p. 650-7. https://doi.org/10.1016/b978-012775390-4/50216-5

Martinez A, Ferrer S, Santos I, Jimenez E, Sparrowe J, Regadera J, et al. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats. Antimicrob Agents Chemother. 2001;45(12):3304-3309. https://doi.org/10.1128/aac.45.12.3304-3309.2001 PMid:11709301

Mohammed AE, Al-Suwaiegh SB. Effects of Nigella sativa on mammals’ health and production. Adv Anim Vet. 2016;4(12):630-6.

Rafati S, Niakan M, Naseri M. Anti-microbial effect of Nigella sativa seed extract against staphylococcal skin Infection. Med J Islam Repub Iran. 2014;28(1):42. PMid:25405108

Downloads

Published

2021-03-07

How to Cite

1.
Rusda M, Adenin I, Siregar MFG, Rambe AYM, Sudewo Y. Therapeutic Effect of 48 h after Nigella sativa Extract Administration on Female Wistar Rats Vaginal Candidiasis Model: An Experimental Study. Open Access Maced J Med Sci [Internet]. 2021 Mar. 7 [cited 2024 May 24];9(T3):6-8. Available from: https://oamjms.eu/index.php/mjms/article/view/5904

Most read articles by the same author(s)

1 2 > >>